189 related articles for article (PubMed ID: 12200552)
1. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients.
Mazal PR; Schaufler R; Altenhuber-Müller R; Haitel A; Watschinger B; Kratzik C; Krupitza G; Regele H; Meisl FT; Zechner O; Kerjaschki D; Susani M
N Engl J Med; 2002 Aug; 347(9):653-9. PubMed ID: 12200552
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic adenomas as renal tubular outposts.
Ingelfinger JR
N Engl J Med; 2002 Aug; 347(9):684-6. PubMed ID: 12200558
[No Abstract] [Full Text] [Related]
3. Nephrogenic adenoma in renal transplant recipients: a truly benign lesion?
Pycha A; Mian C; Reiter WJ; Brössner C; Haitel A; Wiener H; Maier U; Marberger M
Urology; 1998 Nov; 52(5):756-61. PubMed ID: 9801094
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.
Herlitz LC; Tong GX; Hamele-Bena D; Greenebaum E
Diagn Cytopathol; 2008 Jan; 36(1):47-9. PubMed ID: 18064687
[TBL] [Abstract][Full Text] [Related]
5. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
6. Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology.
Varga Z; Gaspert A; Behnke S; von Teichman A; Fritzsche F; Fehr T
Pathol Int; 2012 Apr; 62(4):254-63. PubMed ID: 22449229
[TBL] [Abstract][Full Text] [Related]
7. Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases.
Kao CS; Kum JB; Fan R; Grignon DJ; Eble JN; Idrees MT
Pediatr Dev Pathol; 2013; 16(2):80-5. PubMed ID: 23597251
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic adenoma in renal transplant recipients.
Zeidan BS; Shabtai M; Waltzer WC; Miller F; Rapaport FT
Transplant Proc; 1992 Apr; 24(2):752-4. PubMed ID: 1566505
[No Abstract] [Full Text] [Related]
10. [Outcome of nephrogenic metaplasia of the bladder in kidney transplant recipients].
Karam G; Gaschignard N; Hourmant M; Prunet D; Garcia S; Le Normand L; Buzelin F; Glémain P; Buzelin JM
Prog Urol; 1997 Dec; 7(6):948-52. PubMed ID: 9490139
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic adenoma of the bladder in renal transplant recipients: a report of 9 cases with assessment of deoxyribonucleic acid ploidy and long-term followup.
Fournier G; Menut P; Moal MC; Hardy E; Volant A; Mangin P
J Urol; 1996 Jul; 156(1):41-4. PubMed ID: 8648834
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
[TBL] [Abstract][Full Text] [Related]
13. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
14. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
15. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
18. Analysis of polyomavirus-infected renal transplant recipients' urine specimens: correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysis.
Kipp BR; Sebo TJ; Griffin MD; Ihrke JM; Halling KC
Am J Clin Pathol; 2005 Dec; 124(6):854-61. PubMed ID: 16416734
[TBL] [Abstract][Full Text] [Related]
19. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.
Herawi M; Drew PA; Pan CC; Epstein JI
Hum Pathol; 2010 Apr; 41(4):594-601. PubMed ID: 20060152
[TBL] [Abstract][Full Text] [Related]
20. Donor and recipient contribution to transplant vasculopathy in chronic renal transplant dysfunction.
Boersema M; Rienstra H; van den Heuvel M; van Goor H; van Luyn MJ; Navis GJ; Popa ER; Hillebrands JL
Transplantation; 2009 Dec; 88(12):1386-92. PubMed ID: 20029335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
